These findings reveal the importance of IFNγ signaling and its role in astrocyte iP regulation during chronic stages of neurodegenerative disease, and they highlight the stage-specific roles of IFNγ during MS and EAE. The gene discussed is IFNG; the disease is myeloid sarcoma.